Stressing the importance of choice: Validity of a preclinical free-choice high-caloric diet paradigm to model behavioural, physiological and molecular adaptations during human diet-induced obesity and metabolic dysfunction.


Journal

Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461

Informations de publication

Date de publication:
05 2019
Historique:
received: 27 10 2018
revised: 06 03 2019
accepted: 28 03 2019
pubmed: 9 4 2019
medline: 12 8 2020
entrez: 9 4 2019
Statut: ppublish

Résumé

Humans have engineered a dietary environment that has driven the global prevalence of obesity and several other chronic metabolic diseases to pandemic levels. To prevent or treat obesity and associated comorbidities, it is crucial that we understand how our dietary environment, especially in combination with a sedentary lifestyle and/or daily-life stress, can dysregulate energy balance and promote the development of an obese state. Substantial mechanistic insight into the maladaptive adaptations underlying caloric overconsumption and excessive weight gain has been gained by analysing brains from rodents that were eating prefabricated nutritionally-complete pellets of high-fat diet (HFD). Although long-term consumption of HFDs induces chronic metabolic diseases, including obesity, they do not model several important characteristics of the modern-day human diet. For example, prefabricated HFDs ignore the (effects of) caloric consumption from a fluid source, do not appear to model the complex interplay in humans between stress and preference for palatable foods, and, importantly, lack any aspect of choice. Therefore, our laboratory uses an obesogenic free-choice high-fat high-sucrose (fc-HFHS) diet paradigm that provides rodents with the opportunity to choose from several diet components, varying in palatability, fluidity, texture, form and nutritive content. Here, we review recent advances in our understanding how the fc-HFHS diet disrupts peripheral metabolic processes and produces adaptations in brain circuitries that govern homeostatic and hedonic components of energy balance. Current insight suggests that the fc-HFHS diet has good construct and face validity to model human diet-induced chronic metabolic diseases, including obesity, because it combines the effects of food palatability and energy density with the stimulating effects of variety and choice. We also highlight how behavioural, physiological and molecular adaptations might differ from those induced by prefabricated HFDs that lack an element of choice. Finally, the advantages and disadvantages of using the fc-HFHS diet for preclinical studies are discussed.

Identifiants

pubmed: 30958590
doi: 10.1111/jne.12718
pmc: PMC6593820
doi:

Substances chimiques

Dietary Sugars 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12718

Informations de copyright

© 2019 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.

Références

JAMA. 2014 Feb 26;311(8):806-14
pubmed: 24570244
Nutr Neurosci. 2019 Aug;22(8):541-550
pubmed: 29284375
Front Neurosci. 2013 Oct 07;7:177
pubmed: 24109426
J Neuroendocrinol. 2019 May;31(5):e12718
pubmed: 30958590
Psychopharmacology (Berl). 2012 Mar;220(1):173-81
pubmed: 21892647
Front Behav Neurosci. 2015 Dec 24;9:358
pubmed: 26733840
Arch Gen Psychiatry. 2010 Mar;67(3):220-9
pubmed: 20194822
Endocrinology. 2004 Aug;145(8):3754-62
pubmed: 15142987
Int J Obes (Lond). 2007 Aug;31(8):1286-94
pubmed: 17325683
Appetite. 2018 Jan 1;120:527-535
pubmed: 28988760
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11696-701
pubmed: 12975524
Am J Physiol Regul Integr Comp Physiol. 2015 Mar 15;308(6):R543-55
pubmed: 25568075
Proc Nutr Soc. 2007 Feb;66(1):124-30
pubmed: 17343778
Obesity (Silver Spring). 2010 May;18(5):966-70
pubmed: 20150901
Psychoneuroendocrinology. 2012 Jun;37(6):729-41
pubmed: 21783325
Int J Obes (Lond). 2018 Aug;42(8):1445-1457
pubmed: 29789721
PLoS One. 2013;8(4):e60407
pubmed: 23565243
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1210-6
pubmed: 15314623
Appetite. 2008 Jan;50(1):1-11
pubmed: 17707947
Eur J Pharmacol. 2011 Jun 11;660(1):207-12
pubmed: 21211524
Nutr Res Rev. 2010 Dec;23(2):270-99
pubmed: 20977819
Nat Rev Neurosci. 2018 Apr;19(4):185-196
pubmed: 29467468
Am J Physiol. 1996 Nov;271(5 Pt 2):R1319-26
pubmed: 8945970
Psychopharmacology (Berl). 2009 Jun;204(3):431-43
pubmed: 19205668
Obesity (Silver Spring). 2007 Apr;15(4):798-808
pubmed: 17426312
Cell Metab. 2012 Jun 6;15(6):848-60
pubmed: 22608008
Chronobiol Int. 2015 Mar;32(2):289-98
pubmed: 25317718
Brain Res. 2000 Sep 1;875(1-2):89-95
pubmed: 10967302
J Endocrinol. 2017 Jan;232(1):49-57
pubmed: 27754934
Endocrinology. 2004 Nov;145(11):4880-9
pubmed: 15271881
Endocrinology. 2011 Jul;152(7):2634-43
pubmed: 21521746
Psychoneuroendocrinology. 2014 Sep;47:178-88
pubmed: 25001967
Am J Physiol Endocrinol Metab. 2000 Oct;279(4):E838-45
pubmed: 11001766
Front Neurosci. 2017 May 15;11:270
pubmed: 28555094
Chronobiol Int. 2011 Apr;28(3):216-28
pubmed: 21452917
Am J Physiol Regul Integr Comp Physiol. 2018 Apr 1;314(4):R598-R610
pubmed: 29351425
Metabolism. 2003 Aug;52(8):978-86
pubmed: 12898461
Diabetes Metab Syndr Obes. 2010 Aug 30;3:285-95
pubmed: 21437097
Physiol Behav. 2006 Aug 30;89(1):53-61
pubmed: 16545403
Int J Obes (Lond). 2013 May;37(5):754-7
pubmed: 22868829
Psychoneuroendocrinology. 2015 Dec;62:389-91
pubmed: 26386543
Nutrients. 2017 Sep 06;9(9):
pubmed: 28878197
Am J Clin Nutr. 2013 Jul;98(1):180-8
pubmed: 23676424
Eur J Neurosci. 2013 Apr;37(8):1350-6
pubmed: 23331763
Brain Behav Immun. 2005 Jul;19(4):275-80
pubmed: 15944067
Lancet. 2001 Feb 3;357(9253):354-7
pubmed: 11210998
J Biomed Biotechnol. 2011;2011:351982
pubmed: 21253582
Appetite. 2017 May 1;112:196-200
pubmed: 28089926
Am J Clin Nutr. 2010 Aug;92(2):428-35
pubmed: 20554791
Diabetes Care. 2006 Jun;29(6):1263-8
pubmed: 16732006
J Nutr. 2003 Jan;133(1):127-33
pubmed: 12514279
Am J Physiol Regul Integr Comp Physiol. 2012 Jun;302(11):R1327-39
pubmed: 22496363
Physiol Behav. 2007 Jul 24;91(4):449-58
pubmed: 17543357
Physiol Behav. 2005 Aug 7;85(5):546-56
pubmed: 15996693
Appetite. 2019 Jan 1;132:114-121
pubmed: 30316873
J Hum Nutr Diet. 2003 Feb;16(1):3-11
pubmed: 12581404
Behav Brain Res. 2016 Sep 15;311:167-172
pubmed: 27212119
Endocrinology. 2005 May;146(5):2193-9
pubmed: 15705773
Cell. 2017 Feb 23;168(5):758-774
pubmed: 28235194
Physiol Behav. 2010 May 11;100(2):173-9
pubmed: 20193697
EJNMMI Res. 2011 Dec 16;1(1):37
pubmed: 22214469
Physiol Behav. 2015 Jan;138:208-18
pubmed: 25446204
Int J Obes (Lond). 2013 Mar;37(3):382-9
pubmed: 22508336
Best Pract Res Clin Endocrinol Metab. 2010 Oct;24(5):785-800
pubmed: 21112026
Int J Obes (Lond). 2010 Mar;34(3):537-46
pubmed: 20029382
J Neuroendocrinol. 2014 Jun;26(6):377-85
pubmed: 24698502
Nature. 2018 Apr;556(7702):505-509
pubmed: 29670283
Int J Obes (Lond). 2013 Sep;37(9):1183-91
pubmed: 23229740
Ann N Y Acad Sci. 2004 Dec;1032:208-10
pubmed: 15677412
J Nutr. 2003 Apr;133(4):1081-7
pubmed: 12672923
Physiol Behav. 1999 May;66(3):511-5
pubmed: 10357442
Appetite. 2017 Oct 1;117:263-269
pubmed: 28687372
Int J Obes (Lond). 2005 Jun;29(6):711-9
pubmed: 15809664
Circulation. 1983 May;67(5):968-77
pubmed: 6219830
Hepatology. 2014 Aug;60(2):545-53
pubmed: 24668862
Int J Obes (Lond). 2014 May;38(5):643-9
pubmed: 23979221
Psychoneuroendocrinology. 2010 Jun;35(5):717-28
pubmed: 19939573
J Neuroendocrinol. 2007 May;19(5):364-73
pubmed: 17425611
Nat Med. 1995 Dec;1(12):1311-4
pubmed: 7489415
Physiol Behav. 2012 Jan 18;105(2):325-31
pubmed: 21893075
Cell Metab. 2007 Nov;6(5):414-21
pubmed: 17983587
PLoS One. 2014 Jan 31;9(1):e87729
pubmed: 24498181
Diabetes. 1991 Nov;40(11):1397-403
pubmed: 1936601
Physiol Behav. 1996 Jun;59(6):1123-8
pubmed: 8737902
Nature. 2006 Sep 21;443(7109):289-95
pubmed: 16988703
Nat Rev Neurosci. 2018 Feb;19(2):95-105
pubmed: 29321684
Obes Rev. 2015 Mar;16(3):207-24
pubmed: 25589226
Appetite. 2014 Jun;77:1-12
pubmed: 24582585
Am J Physiol. 1995 Sep;269(3 Pt 2):R641-6
pubmed: 7573567
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20529-34
pubmed: 21059919
J Biol Chem. 2004 Jul 30;279(31):32345-53
pubmed: 15166226
Int J Obes (Lond). 2011 Apr;35(4):595-604
pubmed: 20714332
Physiol Behav. 2015 Nov 1;151:102-10
pubmed: 26150317
Stress. 2015;18(4):381-99
pubmed: 26303312
JAMA. 2016 Jun 7;315(21):2292-9
pubmed: 27272581
Front Endocrinol (Lausanne). 2018 Apr 09;9:154
pubmed: 29686649
Obesity (Silver Spring). 2012 Aug;20(8):1738-40
pubmed: 22307070
Int J Obes Relat Metab Disord. 2003 Apr;27(4):514-21
pubmed: 12664085
Obesity (Silver Spring). 2019 Mar;27(3):409-419
pubmed: 30699240
Neuroscience. 2011 Sep 29;192:351-60
pubmed: 21742017

Auteurs

Margo Slomp (M)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Evita Belegri (E)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Aurea S Blancas-Velazquez (AS)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Charlene Diepenbroek (C)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Leslie Eggels (L)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Myrtille C R Gumbs (MCR)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Anil Joshi (A)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Laura L Koekkoek (LL)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Khalid Lamuadni (K)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Muzeyyen Ugur (M)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Unga A Unmehopa (UA)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Susanne E la Fleur (SE)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Joram D Mul (JD)

Department of Endocrinology and Metabolism, Laboratory of Endocrinology, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Metabolism and Reward Group, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH